Associate Professor, Medicine-Beth Israel Deaconess Medical Center, Harvard Medical School
Gastroenterology
Dr. Michael P. Curry, MD
|
|
Give Review
Dr. Michael P. Curry practices Gastroenterology. He received awards:"Boston Magazine" and "Meaningful Use Stage 1 Certification". Michael P. Curry, MD is a published doctor and has 51 publications published. The lastest was: 'Delayed correction of portal hypertension after portal vein conduit arterialization in liver transplantation.' Michael P. Curry, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.
- Pulmonary Vessel Cross-sectional Area before and after Liver Transplantation: Quantification with Computed Tomography.
- Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
- Low Yield and Utilization of Confirmatory Testing in a Cohort of Patients with Liver Disease Assessed for Alpha-1 Antitrypsin Deficiency.
- Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation.
- Peginterferon and Ribavirin for Treatment of Recurrent Hepatitis C Disease in HCV-HIV Coinfected Liver Transplant Recipients.
- HIV and hepatitis C virus: special concerns for patients with cirrhosis.
- Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study.
- Is model for end-stage liver disease score associated with quality of life after liver transplantation?
- Patients' expectations and success criteria for liver transplantation.
- Early TIPS to improve survival in acute variceal bleeding.
- Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantation.
- Use of growth factors with antiviral therapy for chronic hepatitis C.
- The gallbladder and biliary tract in cystic fibrosis.
- Atypical radiological presentation of progressive multifocal leukoencephalopathy following liver transplantation.
- Hepatitis B and hepatitis C viruses in liver transplantation.
- Minimising cold ischaemic time is essential in cardiac death donor-associated liver transplantation.
- Timing of sirolimus conversion influences recovery of renal function in liver transplant recipients.
- Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver.
- Decrease in hepatic CD56(+) T cells and V alpha 24(+) natural killer T cells in chronic hepatitis C viral infection.
- Expansion of peripheral blood CD5+ B cells is associated with mild disease in chronic hepatitis C virus infection.
- Fatigue and sleep quality before and after liver transplantation.
- Intensive care unit extubation does not preclude extrarenal organ recovery from donors after cardiac death.
- The clinical significance of persistently normal ALT in chronic hepatitis B infection.
- Quality of life and psychosocial functioning of spouse/partner caregivers before and after liver transplantation.
- Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source.
- Comparative rates of nucleotide sequence variation in the hypervariable region of E1/E2 and the NS5b region of hepatitis C virus in patients with a spectrum of liver d...
- Evaluation of Native Kidney Recovery After Simultaneous Liver-Kidney Transplantation.
- Hepatocellular Carcinoma (HCC) in a Patient With Hepatitis B Virus (HBV) Infection.
- Delayed correction of portal hypertension after portal vein conduit arterialization in liver transplantation.
- Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy.
- Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV.
- The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease.
- The role of hepatic arterial Doppler ultrasound after liver transplantation: an ''audit cycle'' evaluation.
- Primary nonfunction (PNF) in the MELD Era: An SRTR database analysis.
- Patients' willingness to accept expanded criteria donor liver transplantation.
- CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons.
- In vitro cold activation of complement shown by an overestimation of total complement 4: a study in patients with hepatitis C virus infection.
- The MHC is a major determinant of viral status, but not fibrotic stage, in individuals infected with hepatitis C.
- Transient elastography for predicting clinical outcomes in patients with chronic liver disease.
- Predicting bone loss following orthotopic liver transplantation.
- Technology evaluation: a critical step in the clinical utilization of novel diagnostic tests for liver fibrosis.
- Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.
- MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates.
- The optimal cut-off for predicting large oesophageal varices using transient elastography is disease specific.
- Isolation of lymphocytes from normal adult human liver suitable for phenotypic and functional characterization.
- The not so good effects of nitric oxide inhibition with methylene blue in cirrhosis and ascites.
- COX 2 inhibitor and fulminant hepatic failure.
- Differential expression of lymphoid and myeloid markers on differentiating hematopoietic stem cells in normal and tumor-bearing adult human liver.
- Spectrum of cancer risk among US solid organ transplant recipients.
Schools
University College Galway National University Of Ireland Faculty Of Medicine and Health Sciences
Doctors Specialties
- Transplant Hepatology
- Gastroenterology
Accepted Insurances
Awards
- Boston Magazine
- Meaningful Use Stage 1 Certification
Hospital
-
Beth Israel Deaconess Medical Center
Drug Facts
| NPI NUMBER | 1518939446 | |
| NPPES Provider LastName | CURRY | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 022155400 | |
| NPPES Provider State | MA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 3066.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 97.0 | |
| Percent Opioid Claims | 3.16 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1518939446 |
| Last Name Of The Provider | CURRY |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Bechien U. Wu, MD |
|
|
Dr. Syed S. Mahmood, MD |
|
|
Disentuwahandi P. De Silva, MB BS
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diana Y. Wu, MD |
|
|
Dr. Ramnik J. Xavier, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Suzanne S. Chan, MD
This Doctor is OpenDoctor Recommended.
|